Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Vilber is a private French life science tools company that designs, manufactures, and commercializes imaging systems for molecular biology and preclinical research. Its portfolio includes instruments for western blot imaging, DNA/RNA gel documentation, UV-based applications, chemiluminescence, fluorescence, bioluminescence, and NIR-II in vivo imaging, along with associated analysis software and workflow tools. The company serves pharmaceutical and biotechnology companies, universities, medical centers, and government research institutes through subsidiaries and distributors in more than 70 countries. Vilber positions itself as a long-established, family-owned manufacturer focused on high-sensitivity optical systems, quantitative image analysis, and integrated production and customer support. The business is best characterized as a commercial life science instrumentation and imaging platform company rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vilber Smart Imaging.